Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Prog Cardiovasc Dis Retrieve available abstracts of 55 articles: HTML format

Single Articles

June 2025
1. KHAN MS, Javaid SS, Mentz RJ, Lindenfeld J, et al
   Heart rate variability in patients with cardiovascular diseases.
   Prog Cardiovasc Dis. 2025 Jun 10:S0033-0620(25)00081.
   PubMed     Abstract available
   
   
   
2. PANTLIN PG, Bharwani S, Chung MK, Morin DP, et al
   Is it safe to use class 1C antiarrhythmic drugs in patients with coronary artery disease and/or cardiomyopathy?
   Prog Cardiovasc Dis. 2025 Jun 9:S0033-0620(25)00080.
   PubMed     Abstract available
   
   
   May 2025
3. KAZIBWE R, Jehopio J, Schaich CL, Rikhi R, et al
   Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension.
   Prog Cardiovasc Dis. 2025 May 18:S0033-0620(25)00069.
   PubMed     Abstract available
   
   
   
4. KERMANSHAHCHI J, Kao AS, Ellberg CC, Duran E, et al
   First presentation of atherosclerotic cardiovascular disease in previously healthy individuals: The multi-ethnic study of atherosclerosis.
   Prog Cardiovasc Dis. 2025 May 14:S0033-0620(25)00075.
   PubMed     Abstract available
   
   
   
5. ROULEAU CR, Garland SN
   A social ecological perspective on interventions to address short sleep duration in adults with coronary heart disease.
   Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00074.
   PubMed     Abstract available
   
   
   
6. TOTH PP, Banach M
   No second chances: Cardiovascular death is the most frequent incident event among patients with coronary artery calcium.
   Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00073.
   PubMed    
   
   
   April 2025
7. LORENZATTI D, Motwani M
   Cardiovascular magnetic resonance in pulmonary hypertension: Keeping it simple.
   Prog Cardiovasc Dis. 2025 Apr 26:S0033-0620(25)00064.
   PubMed    
   
   
   
8. KHAN MS, Rashid AM, Van Spall HGC, Greene SJ, et al
   Integrating cardiovascular implementation science research within healthcare systems.
   Prog Cardiovasc Dis. 2025 Apr 15:S0033-0620(25)00059.
   PubMed     Abstract available
   
   
   March 2025
9. FILTZ A, Gulati M
   Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio.
   Prog Cardiovasc Dis. 2025 Mar 22:S0033-0620(25)00038.
   PubMed    
   
   
   
10. SLIPCZUK L
    Assorted topics in cardiovascular disease 2025: Novel insights in prevention, diagnosis, and treatment.
    Prog Cardiovasc Dis. 2025 Mar 21:S0033-0620(25)00037.
    PubMed    
    
    
    
11. SLIPCZUK L
    Continuing a legacy of excellence: A new chapter for Progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2025 Mar 21:S0033-0620(25)00039.
    PubMed    
    
    
    
12. AHMAD MI, Chevli PA, Mirzai S, Rikhi R, et al
    Waist to hip ratio modifies the cardiovascular risk of lipoprotein (a): Insights from MESA.
    Prog Cardiovasc Dis. 2025 Mar 11:S0033-0620(25)00030.
    PubMed     Abstract available
    
    
    February 2025
13. LIPPI G, Lavie CJ, Gomar FS
    Unveiling the burden of acute myocardial infarction deaths associated with COVID-19 during the first five years of the pandemic.
    Prog Cardiovasc Dis. 2025 Feb 10:S0033-0620(25)00025.
    PubMed    
    
    
    
14. CHAUNTRY AJ, Whittaker AC, Puterman E, Seeman T, et al
    Chronic psychological stress and cardiovascular disease risk: When to use single biomarkers versus allostatic load.
    Prog Cardiovasc Dis. 2025 Feb 8:S0033-0620(25)00026.
    PubMed    
    
    
    January 2025
15. KIM DS, Schuetz N, Johnson A, Tolas A, et al
    Unlocking insights: Clinical associations from the largest 6-minute walk test collection via the my Heart Counts Cardiovascular Health Study, a fully digital smartphone platform.
    Prog Cardiovasc Dis. 2025 Jan 28:S0033-0620(25)00010.
    PubMed     Abstract available
    
    
    
16. CHATURVEDI A, Gadela NV, Kalra K, Chandrika P, et al
    Non-atherosclerotic coronary causes of myocardial infarction in women.
    Prog Cardiovasc Dis. 2025 Jan 27:S0033-0620(25)00008.
    PubMed     Abstract available
    
    
    
17. PATEL RAG, Brilakis ES
    Complex high-risk indicated percutaneous coronary intervention (CHIP): Introduction.
    Prog Cardiovasc Dis. 2025 Jan 22:S0033-0620(25)00006.
    PubMed    
    
    
    
18. AL-OGAILI A, Gill GS, Brilakis ES
    Complications of percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2025 Jan 7:S0033-0620(24)00174.
    PubMed     Abstract available
    
    
    
19. NEALY Z, Wang S, Patel AR
    The complex role of cardiovascular imaging in viability testing.
    Prog Cardiovasc Dis. 2025 Jan 7:S0033-0620(24)00177.
    PubMed     Abstract available
    
    
    
20. SHIN D, Galougahi KK, Singh M, Caron E, et al
    Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease.
    Prog Cardiovasc Dis. 2025 Jan 4:S0033-0620(24)00173.
    PubMed     Abstract available
    
    
    
21. GUPTA A, Maitas O, Patel RAG
    Recurrent drug eluting stent, in-stent restenosis (DES-ISR): Epidemiology, pathophysiology & treatment.
    Prog Cardiovasc Dis. 2025 Jan 2:S0033-0620(24)00172.
    PubMed     Abstract available
    
    
    
22. BAGH I, Patel RAG
    Unprotected distal left main percutaneous intervention.
    Prog Cardiovasc Dis. 2025;88:53-59.
    PubMed     Abstract available
    
    
    
23. HYASAT K, Su CS, Kirtane AJ, McEntegart M, et al
    The efficacy of revascularization in ischemic cardiomyopathy.
    Prog Cardiovasc Dis. 2025;88:105-112.
    PubMed     Abstract available
    
    
    December 2024
24. ALLANA SS, Gondi K, Goyal A, Vallabhajosyula S, et al
    Retrograde approach to chronic total occlusion percutaneous coronary interventions- Technique and outcomes.
    Prog Cardiovasc Dis. 2024 Dec 30:S0033-0620(24)00171.
    PubMed     Abstract available
    
    
    
25. FRIZZELL J, Kereiakes DJ
    Calcified plaque modification during percutaneous coronary revascularization.
    Prog Cardiovasc Dis. 2024 Dec 9:S0033-0620(24)00170.
    PubMed     Abstract available
    
    
    November 2024
26. JAISWAL V, Hanif M, Mashkoor Y, Sawhney A, et al
    Cardiovascular outcomes among giant cell myocarditis compared with cardiac sarcoidosis: A propensity score-matched analysis.
    Prog Cardiovasc Dis. 2024 Nov 16:S0033-0620(24)00152.
    PubMed     Abstract available
    
    
    October 2024
27. LOPES KS, Junior AG, Fillmore N, da Silva Gomes R, et al
    Cardiovascular-kidney-metabolic syndrome - An integrative review.
    Prog Cardiovasc Dis. 2024 Oct 30:S0033-0620(24)00148.
    PubMed     Abstract available
    
    
    
28. BELMONTE M, Foa A, Paolisso P, Bergamaschi L, et al
    Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
    Prog Cardiovasc Dis. 2024 Oct 22:S0033-0620(24)00142.
    PubMed     Abstract available
    
    
    
29. AL ZEIN M, Khazzeka A, El Khoury A, Al Zein J, et al
    Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00146.
    PubMed     Abstract available
    
    
    
30. AL JEBAJE Z, Jabri A, Mishra T, Halboni A, et al
    Use of mechanical circulatory support in high-risk percutaneous coronary interventions.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00143.
    PubMed     Abstract available
    
    
    
31. WANG XJ, Voortman T, de Crom TOE, Tilly M, et al
    Healthy and unhealthy plant-based diets and the risk of cardiovascular diseases: The Rotterdam study and updated meta-analysis.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00144.
    PubMed     Abstract available
    
    
    
32. RUNSEWE OI, Srivastava SK, Sharma S, Chaudhury P, et al
    Optical coherence tomography angiography in cardiovascular disease.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00145.
    PubMed     Abstract available
    
    
    
33. POLO-LOPEZ A, Calatayud J, Lopez-Bueno L, Nunez-Cortes R, et al
    Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants.
    Prog Cardiovasc Dis. 2024 Oct 8:S0033-0620(24)00128.
    PubMed     Abstract available
    
    
    
34. UJJAWAL A, Lobo T, Yaggi HK, Neeland IJ, et al
    The connection between sleep deficiency and coronary artery disease: Complexities and controversies.
    Prog Cardiovasc Dis. 2024 Oct 7:S0033-0620(24)00126.
    PubMed     Abstract available
    
    
    September 2024
35. GAJAGOWNI S, Hopkins S, Qadeer Y, Virani SS, et al
    Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions.
    Prog Cardiovasc Dis. 2024 Sep 13:S0033-0620(24)00117.
    PubMed     Abstract available
    
    
    
36. POWER DA, Hemetsberger R, Farhan S, Abdel-Wahab M, et al
    Calcified coronary lesions: Imaging, prognosis, preparation and treatment state of the art review.
    Prog Cardiovasc Dis. 2024;86:26-37.
    PubMed     Abstract available
    
    
    August 2024
37. COLLET C, Amponsah DK, Mahendiran T, Mizukami T, et al
    Advancements and future perspectives in coronary angiography-derived fractional flow reserve.
    Prog Cardiovasc Dis. 2024 Aug 7:S0033-0620(24)00111.
    PubMed     Abstract available
    
    
    
38. LAVIE CJ
    Cardiovascular statistics 2024.
    Prog Cardiovasc Dis. 2024 Aug 5:S0033-0620(24)00103.
    PubMed    
    
    
    July 2024
39. MASOOMI R, Moscardelli S, Hirai T, Azzalini L, et al
    Antegrade techniques for chronic total occlusion percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2024 Jul 18:S0033-0620(24)00098.
    PubMed     Abstract available
    
    
    
40. KRISHNAN S, Aldana-Bitar J, Golub I, Kianoush S, et al
    Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution.
    Prog Cardiovasc Dis. 2024 Jul 17:S0033-0620(24)00100.
    PubMed    
    
    
    June 2024
41. MONTONE RA, Ford T, Galli M, Rinaldi R, et al
    Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach.
    Prog Cardiovasc Dis. 2024 Jun 25:S0033-0620(24)00091.
    PubMed     Abstract available
    
    
    
42. ROZANSKI A, Gransar H, Park R, Miller RJH, et al
    The ethnic and racial diversity of patients undergoing coronary artery calcium scanning.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00093.
    PubMed     Abstract available
    
    
    
43. LOPEZ-BUENO R, Calatayud J, Del Pozo Cruz J, Yang L, et al
    Dose-response associations of the American Heart Association's new "Life's essential 8" metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00090.
    PubMed     Abstract available
    
    
    
44. AROMIWURA AA, Cavalcante JL, Kwong RY, Ghazipour A, et al
    The role of artificial intelligence in cardiovascular magnetic resonance imaging.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00092.
    PubMed     Abstract available
    
    
    May 2024
45. SOROOSH GP, Tasdighi E, Adhikari R, Blaha MJ, et al
    Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00072.
    PubMed     Abstract available
    
    
    
46. MANUBOLU VS, Ichikawa K, Budoff MJ
    Innovations in cardiac computed tomography: Imaging in coronary artery disease.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00073.
    PubMed     Abstract available
    
    
    
47. GOMEZ S, Dudum R, Rodriguez F
    Inequities in atherosclerotic cardiovascular disease prevention.
    Prog Cardiovasc Dis. 2024 May 9:S0033-0620(24)00071.
    PubMed     Abstract available
    
    
    
48. GAMI A, Bisht S, Satish P, Blaha MJ, et al
    The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults.
    Prog Cardiovasc Dis. 2024 May 7:S0033-0620(24)00069.
    PubMed     Abstract available
    
    
    
49. SATISH P, Avenatti E, Patel J, Agarwala A, et al
    Understanding the spectrum of cardiovascular risk in women - A primer for prevention.
    Prog Cardiovasc Dis. 2024 May 4:S0033-0620(24)00070.
    PubMed     Abstract available
    
    
    
50. ALDANA-BITAR J, Golub IS, Moore J, Krishnan S, et al
    Colchicine and plaque: A focus on atherosclerosis imaging.
    Prog Cardiovasc Dis. 2024;84:68-75.
    PubMed     Abstract available
    
    
    April 2024
51. JAISWAL V, Sawhney A, Nebuwa C, Borra V, et al
    Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials.
    Prog Cardiovasc Dis. 2024 Apr 5:S0033-0620(24)00055.
    PubMed     Abstract available
    
    
    March 2024
52. TUTOR A, O'Keefe EL, Lavie CJ, Elagizi A, et al
    Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00054.
    PubMed     Abstract available
    
    
    
53. LAKSHMANAN S, Wei J, Cook-Wiens G, Pepine CJ, et al
    Comparison of risk profiles of participants in the Women's IschemiA TRial to reduce events in non-ObstRuctive CAD (WARRIOR) trial, using coronary computed tomography angiography vs invasive coronary angiography.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00053.
    PubMed     Abstract available
    
    
    
54. LIPPI G, Sanchis-Gomar F, Lavie CJ
    Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic.
    Prog Cardiovasc Dis. 2024 Mar 20:S0033-0620(24)00051.
    PubMed    
    
    
    February 2024
55. KRISHNAN S, Aldana-Bitar J, Golub I, Ichikawa K, et al
    Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
    Prog Cardiovasc Dis. 2024 Feb 27:S0033-0620(24)00036.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.